MLTX SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001172661-26-003691
MLTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G for MoonLake Immunotherapeutics (MLTX), updating its previously reported passive ownership position. The stock moved -0.2% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for MoonLake Immunotherapeutics (MLTX), updating its previously reported passive ownership position. The filing indicates no change in investment intent and no activist plans.
Key details
How MLTX stock reacted
Close before
$16.50
Aug 13, 2026
First close after
-0.18%
$16.47
5 trading days
-3.82%
$15.87
Since filing
-30.12%
$11.53
✦ Ask GOAX AI about this filing — what it means for MLTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MLTX?
Click hereFrequently asked questions
What did MLTX file with the SEC on Aug 14, 2026?
MLTX filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for MoonLake Immunotherapeutics (MLTX), updating its previously reported passive ownership position. The filing indicates no change in investment intent and no activist plans.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did MLTX stock react to this filing?
MLTX closed at $16.50 before the filing and $16.47 on Aug 14, 2026 (-0.18%). Five trading days later: $15.87 (-3.82%).
Other MLTX SEC filings
- 10-Q · Shelf registrationNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- 8-K · Fda approvalSep 30, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · Fda approvalAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · Secondary offeringJul 15, 2026
- 144 · SEC filingJun 30, 2026
- 8-K · Secondary offeringJun 25, 2026
Get alerts when MLTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days